2015 American Transplant Congress
Geographic Variation in Listing Practices Represents Competetive Behaviors and Access to Care Rather Than Differences in Demand for Liver Transplantation
Purpose: This study evaluates whether program and patient demographics influence liver transplant listing practices.Methods:2013 liver waiting list and transplant (Tx) variables, US Census socioeconomic variables,…2015 American Transplant Congress
Kidney Transplant Patients' Attitudes Towards Self-Management Support: A Q-Methodological Study
Introduction: The objective of this study was to identify profiles of kidney transplant recipients with varying preferences and needs for self-management support (SMS). Insight in…2015 American Transplant Congress
Pre-Transplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Chronic Portal Vein Thrombosis
Northwestern Memorial Hospital, Chicago, IL.
Background: Chronic, occlusive portal vein thrombosis (PVT) associated with cirrhosis represents a relative contraindication to liver transplantation (LT) in some centers. From a surgical perspective,…2015 American Transplant Congress
Not Only CD28null But Also CD28pos T Cells Contribute to Rejection During Belatacept Treatment
To explain the underlying immunological mechanisms for rejection under belatacept treatment, the phenotypical and functional characteristics of graft infiltrating lymphocytes were studied during rejection under…2015 American Transplant Congress
Impact of Sirolimus on the Risk of BK Viremia in Simultaneous Pancreas-Kidney Transplant Recipients
BackgroundBK virus (BKV) is a common infection in simultaneous pancreas-kidney (SPK) transplant recipients. Data in kidney transplant recipients suggest that immunosuppression regimens containing an mTORi…2015 American Transplant Congress
Implications of Living Kidney Donor Histology, Volume and Function on Allograft Outcome
Donor factors are determinants of donor quality and therefore graft function in deceased donation (DD). We hypothesized that analogous to DD, donor factors such as…2015 American Transplant Congress
When Do DCD Donors Die? Outcomes and Implications of DCD at a High-Volume, Single-Center OPO in the United States
Introduction: Successful donation (SD) is not always possible following attempted donation after circulatory death (DCD). The goal of this study was to determine the fate…2015 American Transplant Congress
Impact of Early Urinary Tract Infections on Renal Graft Function
Barnes Jewish Hospital, St Louis, MO.
Purpose: Describe the incidence of early urinary tract infections (UTI) after renal transplantation at a large academic transplant center. Evaluate the impact of early UTIs…2015 American Transplant Congress
Should Current IVIg Preparations Containing High Titers of Anti-HLA-I/-II IgG be Used for Lowering the Anti-HLA IgG in Sensitized Pre-Transplant Patients and Allograft Recipients?
HLA antibodies, Terasaki Foundation Laboratory, Los Angeles, CA.
Sera of non-alloimmunized individuals contain anti-HLA-I & -II IgG. Therefore it is reasonable expect HLA-I/-II reactivity of Intravenous Immunoglobulin (IVIg). However, the titers at which…2015 American Transplant Congress
Retrospective Cohort Study Concerning Efficacy and Safety of Bortezomib in Combination With Or Without Rituximab in Antibody Mediated Rejection in Renal Transplant Recipients
Charité Universitätsmedizin Berlin, Department of Nephrology, Berlin, Germany.
Treatment of antibody-mediated rejection (AMR) in renal transplant (tx) patients (pts) is still challenging and long-term outcome remains unsatisfying. Because plasma cells (PCs) are crucial…
- « Previous Page
- 1
- …
- 132
- 133
- 134
- 135
- 136
- …
- 170
- Next Page »